Preclinical evaluation of efficacy and pharmacokinetics of gentamicin containing extracellular‐matrix envelope
Pacing and Clinical Electrophysiology2020Vol. 43(3), pp. 341–349
Citations Over TimeTop 10% of 2020 papers
Abstract
In this preclinical animal infection model, gentamicin containing ECME was highly effective in reducing bacterial burden in the implant pocket, while systemic exposure after implantation remained low.
Related Papers
- → Polyaspartic Acid Prevents Experimental Aminoglycoside Nephrotoxicity(1989)125 cited
- → A Comparison between the Nephrotoxic Profile of Gentamicin and Gentamicin Nanoparticles in Mice(2014)46 cited
- → Assay of Gentamicin and Tobramycin in Sera of Patients by Gas-Liquid Chromatography(1978)13 cited
- → Effect of Cephalothin on Renal Cortical Concentrations of Gentamicin in Rats(1976)34 cited
- → Renal pharmacokinetic changes of gentamicin during enterococcal pyelonephritis(1988)8 cited